The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Benign Prostatic Hyperplasia Devices-Global Market Insights and Sales Trends 2025

Benign Prostatic Hyperplasia Devices-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1855286

No of Pages : 99

Ask Your Query
Synopsis
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global Benign Prostatic Hyperplasia Devices market size is expected to reach US$ 507.6 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Benign Prostatic Hyperplasia Devices in various end use industries. The expanding demands from the Hospitals and Clinics, Ambulatory Surgical Centers(ASC), Home and Others, are propelling Benign Prostatic Hyperplasia Devices market. Transurethral Resection of the Prostate (TURP), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transurethral Microwave Therapy (TUMT) segment is estimated at % CAGR for the next seven-year period.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Benign Prostatic Hyperplasia Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Benign Prostatic Hyperplasia Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Benign Prostatic Hyperplasia Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Benign Prostatic Hyperplasia Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Benign Prostatic Hyperplasia Devices covered in this report include Lumenis, Olympus corporation, Urologix, Boston Scientific corporation, Lisa Laser, Medifocus, Neotrac, ProArc Medical LTD and Urotech GMBH, etc.
The global Benign Prostatic Hyperplasia Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Lumenis
Olympus corporation
Urologix
Boston Scientific corporation
Lisa Laser
Medifocus
Neotrac
ProArc Medical LTD
Urotech GMBH
Global Benign Prostatic Hyperplasia Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Benign Prostatic Hyperplasia Devices market, Segment by Type:
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
Laser Surgery
Prostatic Stenting
Others
Global Benign Prostatic Hyperplasia Devices market, by Application
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Home
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Benign Prostatic Hyperplasia Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Benign Prostatic Hyperplasia Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Benign Prostatic Hyperplasia Devices Market Overview
1.1 Benign Prostatic Hyperplasia Devices Product Overview
1.2 Benign Prostatic Hyperplasia Devices Market Segment by Type
1.2.1 Transurethral Resection of the Prostate (TURP)
1.2.2 Transurethral Microwave Therapy (TUMT)
1.2.3 Transurethral Needle Ablation of the Prostate (TUNA)
1.2.4 Laser Surgery
1.2.5 Prostatic Stenting
1.2.6 Others
1.3 Global Benign Prostatic Hyperplasia Devices Market Size by Type
1.3.1 Global Benign Prostatic Hyperplasia Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Benign Prostatic Hyperplasia Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Benign Prostatic Hyperplasia Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Benign Prostatic Hyperplasia Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Benign Prostatic Hyperplasia Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Benign Prostatic Hyperplasia Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Breakdown by Type (2018-2023)
2 Global Benign Prostatic Hyperplasia Devices Market Competition by Company
2.1 Global Top Players by Benign Prostatic Hyperplasia Devices Sales (2018-2023)
2.2 Global Top Players by Benign Prostatic Hyperplasia Devices Revenue (2018-2023)
2.3 Global Top Players by Benign Prostatic Hyperplasia Devices Price (2018-2023)
2.4 Global Top Manufacturers Benign Prostatic Hyperplasia Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Benign Prostatic Hyperplasia Devices Market Competitive Situation and Trends
2.5.1 Benign Prostatic Hyperplasia Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Benign Prostatic Hyperplasia Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Benign Prostatic Hyperplasia Devices Market
2.8 Key Manufacturers Benign Prostatic Hyperplasia Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Benign Prostatic Hyperplasia Devices Status and Outlook by Region
3.1 Global Benign Prostatic Hyperplasia Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Benign Prostatic Hyperplasia Devices Historic Market Size by Region
3.2.1 Global Benign Prostatic Hyperplasia Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Benign Prostatic Hyperplasia Devices Sales in Value by Region (2018-2023)
3.2.3 Global Benign Prostatic Hyperplasia Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Benign Prostatic Hyperplasia Devices Forecasted Market Size by Region
3.3.1 Global Benign Prostatic Hyperplasia Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Benign Prostatic Hyperplasia Devices Sales in Value by Region (2024-2029)
3.3.3 Global Benign Prostatic Hyperplasia Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Benign Prostatic Hyperplasia Devices by Application
4.1 Benign Prostatic Hyperplasia Devices Market Segment by Application
4.1.1 Hospitals and Clinics
4.1.2 Ambulatory Surgical Centers(ASC)
4.1.3 Home
4.1.4 Others
4.2 Global Benign Prostatic Hyperplasia Devices Market Size by Application
4.2.1 Global Benign Prostatic Hyperplasia Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Benign Prostatic Hyperplasia Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Benign Prostatic Hyperplasia Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Benign Prostatic Hyperplasia Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Benign Prostatic Hyperplasia Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Benign Prostatic Hyperplasia Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales Breakdown by Application (2018-2023)
5 North America Benign Prostatic Hyperplasia Devices by Country
5.1 North America Benign Prostatic Hyperplasia Devices Historic Market Size by Country
5.1.1 North America Benign Prostatic Hyperplasia Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Benign Prostatic Hyperplasia Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Benign Prostatic Hyperplasia Devices Sales in Value by Country (2018-2023)
5.2 North America Benign Prostatic Hyperplasia Devices Forecasted Market Size by Country
5.2.1 North America Benign Prostatic Hyperplasia Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Benign Prostatic Hyperplasia Devices Sales in Value by Country (2024-2029)
6 Europe Benign Prostatic Hyperplasia Devices by Country
6.1 Europe Benign Prostatic Hyperplasia Devices Historic Market Size by Country
6.1.1 Europe Benign Prostatic Hyperplasia Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Benign Prostatic Hyperplasia Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Benign Prostatic Hyperplasia Devices Sales in Value by Country (2018-2023)
6.2 Europe Benign Prostatic Hyperplasia Devices Forecasted Market Size by Country
6.2.1 Europe Benign Prostatic Hyperplasia Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Benign Prostatic Hyperplasia Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Benign Prostatic Hyperplasia Devices by Region
7.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Historic Market Size by Region
7.1.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Benign Prostatic Hyperplasia Devices Sales in Value by Region (2024-2029)
8 Latin America Benign Prostatic Hyperplasia Devices by Country
8.1 Latin America Benign Prostatic Hyperplasia Devices Historic Market Size by Country
8.1.1 Latin America Benign Prostatic Hyperplasia Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Benign Prostatic Hyperplasia Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Benign Prostatic Hyperplasia Devices Sales in Value by Country (2018-2023)
8.2 Latin America Benign Prostatic Hyperplasia Devices Forecasted Market Size by Country
8.2.1 Latin America Benign Prostatic Hyperplasia Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Benign Prostatic Hyperplasia Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Benign Prostatic Hyperplasia Devices by Country
9.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Historic Market Size by Country
9.1.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Benign Prostatic Hyperplasia Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Lumenis
10.1.1 Lumenis Company Information
10.1.2 Lumenis Introduction and Business Overview
10.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Lumenis Benign Prostatic Hyperplasia Devices Products Offered
10.1.5 Lumenis Recent Development
10.2 Olympus corporation
10.2.1 Olympus corporation Company Information
10.2.2 Olympus corporation Introduction and Business Overview
10.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Products Offered
10.2.5 Olympus corporation Recent Development
10.3 Urologix
10.3.1 Urologix Company Information
10.3.2 Urologix Introduction and Business Overview
10.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Urologix Benign Prostatic Hyperplasia Devices Products Offered
10.3.5 Urologix Recent Development
10.4 Boston Scientific corporation
10.4.1 Boston Scientific corporation Company Information
10.4.2 Boston Scientific corporation Introduction and Business Overview
10.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Products Offered
10.4.5 Boston Scientific corporation Recent Development
10.5 Lisa Laser
10.5.1 Lisa Laser Company Information
10.5.2 Lisa Laser Introduction and Business Overview
10.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Products Offered
10.5.5 Lisa Laser Recent Development
10.6 Medifocus
10.6.1 Medifocus Company Information
10.6.2 Medifocus Introduction and Business Overview
10.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Medifocus Benign Prostatic Hyperplasia Devices Products Offered
10.6.5 Medifocus Recent Development
10.7 Neotrac
10.7.1 Neotrac Company Information
10.7.2 Neotrac Introduction and Business Overview
10.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Neotrac Benign Prostatic Hyperplasia Devices Products Offered
10.7.5 Neotrac Recent Development
10.8 ProArc Medical LTD
10.8.1 ProArc Medical LTD Company Information
10.8.2 ProArc Medical LTD Introduction and Business Overview
10.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Products Offered
10.8.5 ProArc Medical LTD Recent Development
10.9 Urotech GMBH
10.9.1 Urotech GMBH Company Information
10.9.2 Urotech GMBH Introduction and Business Overview
10.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Products Offered
10.9.5 Urotech GMBH Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Benign Prostatic Hyperplasia Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Benign Prostatic Hyperplasia Devices Industrial Chain Analysis
11.4 Benign Prostatic Hyperplasia Devices Market Dynamics
11.4.1 Benign Prostatic Hyperplasia Devices Industry Trends
11.4.2 Benign Prostatic Hyperplasia Devices Market Drivers
11.4.3 Benign Prostatic Hyperplasia Devices Market Challenges
11.4.4 Benign Prostatic Hyperplasia Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Benign Prostatic Hyperplasia Devices Distributors
12.3 Benign Prostatic Hyperplasia Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock